Status:
RECRUITING
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
Lead Sponsor:
British Columbia Cancer Agency
Collaborating Sponsors:
University of Texas Southwestern Medical Center
Van Andel Research Institute
Conditions:
Ovarian Cancer
Ascites
Eligibility:
FEMALE
18+ years
Brief Summary
The objective of the study is to investigate the metabolism of cells in the ascites tumour microenvironment of ovarian cancer patients. This observational study involves intravenous infusion of \[U-13...
Detailed Description
Participants and Location: This study will recruit up to 10 patients of at least 18 years of age with ascites due to diagnosed ovarian cancer. Eligible study patients will be screened and recruited a...
Eligibility Criteria
Inclusion Criteria:
- Ovarian cancer
- Any stage or grade of disease
- Ascites fluid that requires draining
- Any treatment regimen
- Primary or recurrent ascites
- Understands the concept of the study and give informed consent.
Exclusion Criteria:
- Participants must not have diabetes or abnormal hemoglobin A1C levels.
- The patient's glucose levels must be between 4 - 11.1 mM before administering an infusion. This is to ensure that patients are within normal blood glucose levels, as described by Diabetes Canada.
- Participants cannot receive chemotherapy treatment during the 5 hour duration of the experiment as it may compromise the integrity of the data.
Key Trial Info
Start Date :
October 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05025878
Start Date
October 20 2021
End Date
August 1 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jennifer Rauw
Victoria, British Columbia, Canada